Compliance with Hepatitis B Vaccination Guidelines for Children and Adolescents Aged 3 to 17 in Germany from 2014 to 2017: Findings from a National Cross-Sectional Study - Report - MDSpire
Advertisement
Compliance with Hepatitis B Vaccination Guidelines for Children and Adolescents Aged 3 to 17 in Germany from 2014 to 2017: Findings from a National Cross-Sectional Study
Compliance with Hepatitis B Vaccination Guidelines for Children in Germany
Overview
This study assesses the adherence to hepatitis B vaccination guidelines among children and adolescents aged 3 to 17 in Germany from 2014 to 2017. Findings indicate a significant gap in vaccination coverage and adherence to recommended dosing schedules, highlighting the need for improved strategies to meet public health goals.
Background
Hepatitis B virus (HBV) poses a significant public health threat, particularly in Europe, where it is a leading cause of chronic liver disease. Effective vaccination strategies are crucial for prevention, especially in childhood, as early infection can lead to chronic conditions. The WHO aims for the elimination of viral hepatitis as a public health threat by 2030, necessitating high vaccination coverage.
Data Highlights
No specific numerical data or trial data was provided in the source material.
Key Findings
Vaccination coverage for HBV in Germany ranged from 86.9% to 88.3% between 2013 and 2018.
For children born in 2016, HBV vaccination coverage at 24 months was estimated at 75.5%.
Only 42% of children born in 2014 completed the recommended vaccination series by 15 months of age.
There has been a persistent gap between DPT and HBV vaccination coverage, although this gap has been closing since 2015.
Adherence to the recommended six-month interval between the last two doses of HBV vaccination is not consistently reported.
Clinical Implications
Suggest specific strategies or programs that have been effective in other regions.
Conclusion
Reiterate the importance of aligning with WHO goals and suggest potential interventions.
